Patients with SMDS due to pathogenic variants altering SMA arginine 179 have MMD-like cerebrovascular disease, with ischemic lesions evident shortly after birth and up to 40% of the patients having critical stenoses of the ICA and/or its branches10. This evidence concerns the gene SMN1 and multiminicore myopathy.